Scientists believe they now have compelling evidence to support theories that mutated BAP1 genes are where the action’s at when it comes to treating mesothelioma with advanced therapeutic agents. Researchers from Memorial Sloan Kettering Cancer Institute in New York City recently announced the results of an investigation confirming that there is a high prevalence of